What's new

Human medicines European public assessment report (EPAR): Inflectra, infliximab, Date of authorisation: 10/09/2013, Revision: 32, Status: Authorised

Human medicines European public assessment report (EPAR): Inflectra, infliximab, Date of authorisation: 10/09/2013, Revision: 32, Status: Authorised

May 27, 2025 - 16:15
 0
Human medicines European public assessment report (EPAR): Inflectra, infliximab, Date of authorisation: 10/09/2013, Revision: 32, Status: Authorised
Human medicines European public assessment report (EPAR): Inflectra, infliximab, Date of authorisation: 10/09/2013, Revision: 32, Status: Authorised
Read More

Tags:

Previous Article

Human medicines European public assessment report (EPAR): HyQvia, human normal i...

Next Article

Start of procedure - extension of marketing authorisation (26 April - 22 May 2025)

Related Posts

Confidentiality undertaking for observers

May 16, 2025  0

Human medicines European public assessment report (EPAR): Spikevax (previously COVID-19 Vaccine Moderna), COVID-19 mRNA vaccine, Date of authorisation: 06/01/2021, Revision: 55, Status: Authorised

Human medicines European public assessment report (EPAR...

May 14, 2025  0

Human medicines European public assessment report (EPAR): Olanzapine Teva, olanzapine, Date of authorisation: 12/12/2007, Revision: 32, Status: Authorised

Human medicines European public assessment report (EPAR...

May 12, 2025  0